Showing results (41-50 of 209) with videos related to
Sort By:
Pageof 21
British Journal of Cancer|August 1, 1993
Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing timeD J Chaplin, M R Horsman, D W SiemannThe British Journal of Radiology|February 1, 1997
Nicotinamide reduces tumour interstitial fluid pressure in a dose- and time-dependent mannerC E Peters, D J Chaplin, D G HirstCancer Investigation|September 6, 2017
Realizing the Potential of Vascular Targeted Therapy: The Rationale for Combining Vascular Disrupting Agents and Anti-Angiogenic Agents to Treat CancerD W Siemann, D J Chaplin, M R HorsmanBiomedica Biochimica Acta|January 1, 1989
Reduction of tumour blood flow by vasoactive drugs: a role in cancer therapyD J Chaplin, B D Acker, M R HorsmanBritish Journal of Cancer|January 1, 1991
Nicotinamide, Fluosol DA and Carbogen: a strategy to reoxygenate acutely and chronically hypoxic cells in vivoD J Chaplin, M R Horsman, D S AokiInternational Journal of Radiation Oncology, Biology, Physics|September 1, 1987
Cytotoxicity of RSU 1069 in spheroids and murine tumorsP L Olive, R E Durand, D J ChaplinCancer Research|January 15, 1987
Intermittent blood flow in a murine tumor: radiobiological effectsD J Chaplin, P L Olive, R E DurandJournal of the National Cancer Institute|April 18, 1990
Effect of nicotinamide on the microregional heterogeneity of oxygen delivery within a murine tumorD J Chaplin, M R Horsman, M J TrotterEuropean Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Effect of angiotensin II on intermittent tumour blood flow and acute hypoxia in the murine SCCVII carcinomaM J Trotter, D J Chaplin, P L OliveBritish Journal of Cancer|March 10, 2001
Proportion of infiltrating IgG-binding immune cells predict for tumour hypoxiaD R Collingridge, S A Hill, D J ChaplinPageof 21